SNY
Stock Details
SNY is Sanofi's stock. Stock exchange NasdaqGS (Currency USD). Average price in 50 days is 41.54$. Average daily volumn in 3 months 2.83M. Market cap 116.28B
Stock symbol : SNY. Exchange : NasdaqGS. Currency : USD Lastest price : 45.87$. Total volume : 1.99M. Market state PRE Click reload if you want to check the lastest price on market!!!
Sanofi (SNY)
Last Price
45.87$Change
0.52Volume
1.99M
| Previous Close | 45.35 |
| Open | 45.90 |
| Day Range | 45.62-46.02 |
| Bid | 0.00 x 1k |
| Ask | 0.00 x 900 |
| Volume | 1.99M |
| Average Volume | 2.83M |
| Market Cap | 116.28B |
| Beta | 0.46 |
| 52 Week Range | 36.91-58.10 |
| Trailing P/E | 17.37 |
| Foward P/E | 10.26 |
| Dividend (Yield %) | 3.81% |
| Ex-Dividend Date | 2022-05-26 |
Financial Details
Organization
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antibodies; products for multiple sclerosis, neurology, other inflammatory diseases, immunology, rare diseases, oncology, and rare blood disorders; medicines ... for diabetes; and cardiovascular and established prescription products. It also supplies poliomyelitis, pertussis, and hib pediatric vaccines; and influenza, adult booster, meningitis, and travel and endemic vaccines. In addition, the company offers allergy, cough and cold, pain, liver care, physical and mental wellness, probiotics, digestive, and nutritional products; and other products, such as daily body lotions, anti-itch products, moisturizing and soothing lotions, and body and foot creams, as well as powders for eczema. Further, it has various pharmaceutical products and vaccines in development stage. Sanofi has collaboration agreement with GlaxoSmithKline to develop a recombinant Covid-19 vaccine; and a research collaboration with Stanford University School of Medicine to advance the understanding of immunology and inflammation through open scientific exchange. It also has a collaboration and license option agreement with Prellis Biologics, Inc. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was founded in 1973 and is headquartered in Paris, France.
Market Cap:
116.28BRevenue:
39.17BTotal Assets:
120.24BTotal Cash:
10.1B
News about "Sanofi"
Sanofi employees renew strike after failed pay rise talks
Source from : EURACTIV - 11 hours ago
Sanofi’s employees decided to renew the industrial action on Thursday after negotiations with management for higher wages in the context of inflation failed. The strike, called by the four main French ...See details»
Press Release: Statement from Sanofi regarding: rule 2.12 of the takeover rules
Source from : YAHOO!Finance - 11 hours ago
THIS IS AN ANNOUNCEMENT FALLING UNDER RULE 2.12 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2022 (THE "TAKEOVER RULES"). NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, ...See details»
Sanofi, DNDi's drug shows success rates of up to 95% for sleeping sickness in trial
Source from : Seeking Alpha - 2 days ago
Sanofi (SNY) said a single-dose of acoziborole showed treatment success rates of up to 95% in a phase 2/3 trial in patients with sleeping sickness.Sanofi noted that the results ...See details»
UK regulator says reactions in eye from Sanofi drug must be quickly reviewed
Source from : Reuters - 2 days ago
Sanofi logo at the company's headquarters during the annual results news conference in Paris, France, February 4, 2022. REUTERS/Benoit Tessier/File Photo Nov 29 (Reuters) - Britain's medicines ...See details»
UK regulator calls for review of reactions in eyes to Sanofi asthma drug
Source from : Reuters on MSN - 3 days ago
Sanofi logo at the company's headquarters during the annual results news conference in Paris, France, February 4, 2022. REUTERS/Benoit Tessier/File Photo ...See details»
Sanofi welcomes 500 staffers to new Paris HQ after €30M renovation
Source from : ENDPOINTS NEWS - 3 days ago
When Paul Hudson took the helm at Sanofi back in 2019, he promised to reinvent the pharma giant — including its Paris headquarters. This week, the company set up shop in new “state-of-the-art” digs.See details»
Media Update: Sanofi to present new clinical data reinforcing novel therapies across rare blood disorders at ASH 2022
Source from : sanofi - 2 days ago
Sanofi to present new clinical data reinforcing novel therapies across rare blood disorders at ASH 2022. Quality of life data for efanesoctocog alfa supports its potential as a tr ...See details»
Sanofi (SNYNF) Receives a Hold from Barclays
Source from : Business Insider - 2 days ago
In a report released today, Emily Field from Barclays maintained a Hold rating on Sanofi (SNYNF - Research Report), with a price target of ...See details»
Sanofi Drug Raises Hopes of Wiping Out Sleeping Sickness
Source from : Bloomberg L.P. - 2 days ago
A drug co-developed by Sanofi is highly effective at treating the sometimes lethal disease called sleeping sickness and could help eradicate the ailment by the end of the decade. While the disease is ...See details»
Sanofi signs latest billion-dollar AI drug discovery deal
Source from : VentureBeat - 24 days ago
The research collaboration comes on the heels of several other high-value AI drug discovery partnership announcements from Sanofi, including with Atomwise in August; a partnership expansion with ...See details»
Sanofi signs research tie-up with Hong Kong’s Insilico Medicine to accelerate AI-powered drug discovery
Source from : scmp.com - 5 days ago
Sanofi has signed a strategic research collaboration with Hong Kong-based biotech firm Insilico Medicine in a deal worth up to US$1.2 billion, leveraging artificial intelligence (AI) to speed up ...See details»
Sanofi, GSK Score Late Win With EU COVID Booster Approval
Source from : U.S. News & World Report - 22 days ago
Sanofi, GSK Score Late Win With EU COVID Booster Approval By Ludwig Burger (Reuters) -Sanofi said on Thursday it won European Union approval for its COVID-19 vaccine booster, jointly made with ...See details»
Sanofi Inks Another AI Alliance, This Time Partnering With Insilico Medicine
Source from : MedCity News - 19 days ago
Sanofi has been an active dealmaker in the artificial intelligence space, an effort intended to beef up its capabilities in drug discovery and development. Insilico Medicine is now the latest AI ...See details»
Sanofi: Information concerning the total number of voting rights and shares – October 2022
Source from : Yahoo - 17 days ago
Sanofi a French société anonyme with a registered share capital of 2,534,952,234 € Registered office : 46, avenue de la Grande Armée - 75017 Paris - France Registered at the Paris Commercial ...See details»